NIMI
RDY icon

Natixis Investment Managers International’s Dr. Reddy's Laboratories RDY Stock Holding History

Natixis Investment Managers International’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-30,400
Closed -$307K – 452
2014
Q4 		$307K Hold
30,400
– – 0.04% 242
2014
Q3 		$320K Sell
30,400
-2,600
-8% -$24.4K 0.05% 147
2014
Q2 		$285K Sell
33,000
-192,000
-85% -$1.61M 0.04% 167
2014
Q1 		$1.98M Buy
+225,000
New +$1.96M 0.28% 67

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.76% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Natixis Investment Managers International's RDY Position: Q1 2015 in Review

Natixis Investment Managers International sold out of Dr. Reddy's Laboratories (RDY) in Q1 2015, closing a stake of 30,400 shares — an estimated $307K sold.

Natixis Investment Managers International first reported a position in RDY in Q1 2014 and held it in 4 quarters. The position peaked at $1.98M in Q1 2014. 174 funds tracked by Wall St. Rank hold RDY as of Q1 2015.

  • Natixis Investment Managers International reported no remaining Dr. Reddy's Laboratories position as of Q1 2015 after selling out during the quarter.
  • Natixis Investment Managers International sold 30,400 Dr. Reddy's Laboratories shares in Q1 2015, an estimated $307K.
  • Natixis Investment Managers International first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 4 quarters.
  • Natixis Investment Managers International's Dr. Reddy's Laboratories position peaked at $1.98M in Q1 2014.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2015.

Based on Natixis Investment Managers International's 13F filing for Q1 2015, filed 22 May 2015.